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Fig．8．　Effbct　of　repeated　i．t，　treatment　with　tlle　selective　PKA　inhibitor　KT－57200n　thermal　hyperalgesia　induced　by　nerve
　　　　　　ligation（A）and　CFA　il亘ection（B）ill　mice．　Groups　of　mice　were　repeatedly　treated　i．t．　with　KT－5720（10，30　and　100
　　　　　　pmoVmouse）〔〕r　vehicle（VEH）30　mill　befbre　nerve　Iigation（A）or　CFA　injection｛B），　and　once　a　day　fbr　7　consecutive
　　　　　　days　after　nerve　hgation　or　CFA　injection，　respectively．　Data　sllow　the　latency　ofpaw　withdrawal　ill　respollse　to　a　ther－
　　　　　　mal　stimulus　oIl　t1〕e　ipsilateral　side　7　days　af七er　nel、・e　ligation　or　CFA　iIλiection　in　mice．　Each　column　represents　the
　　　　　　meall±S．E．M．　of　6　mice．：…；＊；…：p〈0．001　vs．　VEH－Sham　or　VEH－Saline　group，耕＃p＜0．001vs．　VEH－CFA　group．　n、s．；not
　　　　　　significant．
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　　　Neuropathic　pain，　which　is　charactedzed　by　spontaneous　burning　pain，　hyperalgesia（exaggerated　pain　in　response　to
painf㎞l　stimuli）and　allodynia（pain　caused　by　normally　innocuous　stimuli），　is　the　most　dif五cult　pain　to　manage　in　the　pain
clinic，　because　the　pain　is　often　re丘actory　to　general　analgesics　such　as　non－steroidal　anti－inflammatory　drugs　and　morphine，
which　are　usually　used　fbr　inflammatory　pain．　There｛bre，　there　seems　to　be　dif丘rences　in　the　mechanisms　of　pain　processing
between　neuropathic　and　inflammatory　pain．　However，　the　respective　detailed　mechanisms　are　not　f已lly　understood．　The　pre－
sent　study　was　then　undertaken　to　investigate　the　dif琵rences　in　the　mechanisms　of　pain　processing　between　neuropathic　and
innammatory　pain　usmg　behavioral，　biochemical　and　immunohistochemical　approaches．　The　present　findings　demon8trated
that　the　activation　of　a　brain－derived　neurotrophic　factor！血ll－length　Trk助）rotein　kinase　C－mediated　signaling　pathway　in　the
spinal　cord　might　be　responsible　fbr　the　development　of　a　neuropathic　pain－like　state．　In　contrast，　the　activation　of　protein
kinase　A　in　the　spinal　cord　may　predominantly　contribute　to　the　development　of　an　innammatory　pain－like　state　in　mice．　Con．
clusively，　these　findings　provide　evidence　that　there　are　diHbrent　mechanisms　of　pain　processing　in　the　spinal　cord　between
neuropathic　and　inflammatory　pain－like　states．
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